ArticleInvestigational new drugs2023

A novel bivalent anti-c-MET/PD-1 bispecific antibody exhibits potent cytotoxicity against c-MET/PD-L1-positive colorectal cancer.

Z Sun et al.PubMed ↗Publisher ↗

No numbers read from the abstract.